Pacific Biosciences of California Inc (NASDAQ:PACB) Is Likely To Perform Well Over The Long Term. Lost Nearly -12.98% Last Month.
In last trading session, Pacific Biosciences of California Inc (NASDAQ:PACB) saw 6.79 million shares changing hands with its beta currently measuring 2.15. Company’s recent per